IDYA

IDEAYA Biosciences, Inc.

46.80 USD
+0.58 (+1.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

IDEAYA Biosciences, Inc. stock is up 7.36% since 30 days ago. The next earnings date is May 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 March’s closed higher than February. In the last 4 Unusual Options Trades, there were 1 CALL, 3 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
05 Jan 19:16 19 Jul, 2024 40.00 CALL 96 6
26 Jan 20:36 15 Mar, 2024 45.00 PUT 79 2
26 Jan 20:36 15 Mar, 2024 45.00 PUT 74 2
26 Jan 20:36 15 Mar, 2024 45.00 PUT 120 2

About IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc. focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions.

  • JP Morgan
    Fri Feb 23, 12:21
    buy
    confirm
  • RBC Capital
    Wed Feb 21, 10:18
    buy
    confirm